Annual Total Liabilities:
$4.23B+$184.21M(+4.55%)Summary
- As of today, ALNY annual total liabilities is $4.23 billion, with the most recent change of +$184.21 million (+4.55%) on December 31, 2024.
- During the last 3 years, ALNY annual total liabilities has risen by +$1.18 billion (+38.61%).
- ALNY annual total liabilities is now at all-time high.
Performance
ALNY Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Liabilities:
$4.62B+$302.34M(+7.01%)Summary
- As of today, ALNY quarterly total liabilities is $4.62 billion, with the most recent change of +$302.34 million (+7.01%) on September 30, 2025.
- Over the past year, ALNY quarterly total liabilities has increased by +$445.08 million (+10.67%).
- ALNY quarterly total liabilities is now at all-time high.
Performance
ALNY Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ALNY Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +4.5% | +10.7% |
| 3Y3 Years | +38.6% | +28.2% |
| 5Y5 Years | +342.8% | +120.7% |
ALNY Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +38.6% | at high | +28.2% |
| 5Y | 5-Year | at high | +342.8% | at high | +120.7% |
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% |
ALNY Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $4.62B(+7.0%) |
| Jun 2025 | - | $4.32B(+5.3%) |
| Mar 2025 | - | $4.10B(-3.2%) |
| Dec 2024 | $4.23B(+4.5%) | $4.23B(+1.5%) |
| Sep 2024 | - | $4.17B(+4.0%) |
| Jun 2024 | - | $4.01B(-0.8%) |
| Mar 2024 | - | $4.04B(-0.2%) |
| Dec 2023 | $4.05B(+9.3%) | $4.05B(+1.1%) |
| Sep 2023 | - | $4.00B(+5.1%) |
| Jun 2023 | - | $3.81B(+4.4%) |
| Mar 2023 | - | $3.65B(-1.4%) |
| Dec 2022 | $3.70B(+21.3%) | $3.70B(+2.8%) |
| Sep 2022 | - | $3.60B(+14.2%) |
| Jun 2022 | - | $3.15B(+4.0%) |
| Mar 2022 | - | $3.03B(-0.7%) |
| Dec 2021 | $3.06B(+27.8%) | $3.06B(+12.5%) |
| Sep 2021 | - | $2.72B(+2.3%) |
| Jun 2021 | - | $2.66B(+14.0%) |
| Mar 2021 | - | $2.33B(-2.6%) |
| Dec 2020 | $2.39B(+150.0%) | $2.39B(+14.3%) |
| Sep 2020 | - | $2.09B(+6.0%) |
| Jun 2020 | - | $1.97B(+112.4%) |
| Mar 2020 | - | $929.89M(-2.8%) |
| Dec 2019 | $956.44M(+250.6%) | $956.44M(+2.3%) |
| Sep 2019 | - | $934.53M(-2.6%) |
| Jun 2019 | - | $959.22M(+105.4%) |
| Mar 2019 | - | $467.01M(+71.2%) |
| Dec 2018 | $272.84M(+19.5%) | $272.84M(+38.1%) |
| Sep 2018 | - | $197.53M(+17.2%) |
| Jun 2018 | - | $168.59M(+0.2%) |
| Mar 2018 | - | $168.33M(-26.3%) |
| Dec 2017 | $228.30M(-33.4%) | $228.30M(-23.8%) |
| Sep 2017 | - | $299.45M(-3.8%) |
| Jun 2017 | - | $311.32M(+2.7%) |
| Mar 2017 | - | $303.02M(-11.5%) |
| Dec 2016 | $342.59M(+181.3%) | $342.59M(+15.0%) |
| Sep 2016 | - | $297.94M(+5.0%) |
| Jun 2016 | - | $283.68M(+121.8%) |
| Mar 2016 | - | $127.90M(+5.0%) |
| Dec 2015 | $121.80M(-15.0%) | $121.80M(+6.3%) |
| Sep 2015 | - | $114.54M(-6.2%) |
| Jun 2015 | - | $122.17M(-7.6%) |
| Mar 2015 | - | $132.28M(-7.7%) |
| Dec 2014 | $143.33M | $143.33M(+75.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $81.88M(-9.4%) |
| Jun 2014 | - | $90.39M(-27.9%) |
| Mar 2014 | - | $125.32M(-16.6%) |
| Dec 2013 | $150.18M(-2.1%) | $150.18M(+0.2%) |
| Sep 2013 | - | $149.92M(-2.9%) |
| Jun 2013 | - | $154.38M(-3.5%) |
| Mar 2013 | - | $160.02M(+4.3%) |
| Dec 2012 | $153.47M(-6.4%) | $153.47M(+5.7%) |
| Sep 2012 | - | $145.19M(+11.5%) |
| Jun 2012 | - | $130.19M(-8.9%) |
| Mar 2012 | - | $142.92M(-12.8%) |
| Dec 2011 | $163.92M(-30.3%) | $163.92M(-10.1%) |
| Sep 2011 | - | $182.35M(-10.7%) |
| Jun 2011 | - | $204.28M(-8.6%) |
| Mar 2011 | - | $223.49M(-4.9%) |
| Dec 2010 | $235.03M(-20.3%) | $235.03M(-3.4%) |
| Sep 2010 | - | $243.39M(-8.5%) |
| Jun 2010 | - | $266.03M(-6.0%) |
| Mar 2010 | - | $282.90M(-4.1%) |
| Dec 2009 | $294.86M(-15.1%) | $294.86M(-4.4%) |
| Sep 2009 | - | $308.33M(-6.2%) |
| Jun 2009 | - | $328.56M(-6.2%) |
| Mar 2009 | - | $350.18M(+0.9%) |
| Dec 2008 | $347.17M(+17.8%) | $347.17M(-7.6%) |
| Sep 2008 | - | $375.62M(-1.4%) |
| Jun 2008 | - | $380.88M(+34.4%) |
| Mar 2008 | - | $283.44M(-3.8%) |
| Dec 2007 | $294.62M(+658.7%) | $294.62M(-5.6%) |
| Sep 2007 | - | $312.16M(+672.9%) |
| Jun 2007 | - | $40.39M(+8.2%) |
| Mar 2007 | - | $37.31M(-3.9%) |
| Dec 2006 | $38.83M(+6.2%) | $38.83M(-2.3%) |
| Sep 2006 | - | $39.75M(+7.3%) |
| Jun 2006 | - | $37.04M(+3.5%) |
| Mar 2006 | - | $35.77M(-2.2%) |
| Dec 2005 | $36.57M(+83.2%) | $36.57M(+81.2%) |
| Sep 2005 | - | $20.18M(-6.0%) |
| Jun 2005 | - | $21.47M(+11.6%) |
| Mar 2005 | - | $19.24M(-3.6%) |
| Dec 2004 | $19.96M(+197.9%) | $19.96M(+13.7%) |
| Sep 2004 | - | $17.56M(-1.3%) |
| Jun 2004 | - | $17.80M(+54.2%) |
| Mar 2004 | - | $11.54M(-81.3%) |
| Dec 2003 | $6.70M(+150.7%) | $61.89M |
| Dec 2002 | $2.67M | - |
FAQ
- What is Alnylam Pharmaceuticals, Inc. annual total liabilities?
- What is the all-time high annual total liabilities for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. annual total liabilities year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. quarterly total liabilities?
- What is the all-time high quarterly total liabilities for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
What is Alnylam Pharmaceuticals, Inc. annual total liabilities?
The current annual total liabilities of ALNY is $4.23B
What is the all-time high annual total liabilities for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high annual total liabilities is $4.23B
What is Alnylam Pharmaceuticals, Inc. annual total liabilities year-on-year change?
Over the past year, ALNY annual total liabilities has changed by +$184.21M (+4.55%)
What is Alnylam Pharmaceuticals, Inc. quarterly total liabilities?
The current quarterly total liabilities of ALNY is $4.62B
What is the all-time high quarterly total liabilities for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high quarterly total liabilities is $4.62B
What is Alnylam Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
Over the past year, ALNY quarterly total liabilities has changed by +$445.08M (+10.67%)